COMMUNIQUÉS West-GlobeNewswire

Theratechnologies annonce ses résultats financiers pour l’exercice 2017
07/02/2018
MONTRÉAL, 07 févr. 2018 (GLOBE NEWSWIRE) -- Theratechnologies inc. (« Theratechnologies ») (TSX: TH ) a annoncé aujourd’hui ses résultats financiers pour l’exercice clos le 30 novembre 2017. Faits saillants financiers [...]
Theratechnologies Announces Financial Results for Fiscal Year 2017
07/02/2018
MONTREAL, Feb. 07, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH ) today announced its financial results for the year ended November 30, 2017. Fiscal Year 2017 Financial Highlights Record [...]
Forward Pharma to Present at the 7th Annual Leerink Partners Global Healthcare Conference
07/02/2018
COPENHAGEN, Denmark, Feb. 07, 2018 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ: FWP ) (the “Company”) today announced that Dr. Claus Bo Svendsen, the Company’s Chief Executive Officer, will give a corporate update at [...]
OpGen Announces Closing of $12 Million Public Offering
07/02/2018
GAITHERSBURG, Md., Feb. 07, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN ) announces the closing of its previously announced public offering of 2,841,152 units at $3.25 per unit and 851,155 pre-funded units at $3. [...]
REPEAT: Cannabis Wheaton Income Corp. Reminds Warrant Holders of February 15, 2018 Expiry Date
07/02/2018
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION TO UNITED STATES VANCOUVER, British Columbia, Feb. 07, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX-V: [...]
Myriad’s myRisk® Hereditary Cancer Test Finds More Than 12 Percent of Men with Prostate Cancer Carry an Inherited Genetic Mutation
07/02/2018
SALT LAKE CITY, Feb. 07, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics , Inc. (NASDAQ: MYGN ), a leader in molecular diagnostics and personalized medicine, announced today that results from a large 1,162 patient study of the [...]
ObsEva SA to present at the LEERINK Partners 7th Annual Global Healthcare Conference February 14th 2018
07/02/2018
Geneva, Switzerland and Boston, MA - February 7, 2018 - ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions [...]
Anavex Life Sciences Provides Clinical Programs Update and Reports Fiscal First Quarter 2018 Financial Results
07/02/2018
Conference Call and Webcast Today at 4:30 p.m. ET NEW YORK, Feb. 07, 2018 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL ), a clinical-stage biopharmaceutical company developing [...]
Kamada Reports Financial Results for Fourth Quarter and Full-Year 2017
07/02/2018
Total Revenues for Fiscal 2017 were $102.8 Million, up 33% Over Fiscal 2016; Exceeded Full-Year Revenue Guidance of $100 Million Full-Year Proprietary Products Revenues up 42% Year-Over-Year Gross Profit for 2017 Grew [...]
VitalHub Introduces WellLinc Interoperability Solution
07/02/2018
TORONTO, Feb. 07, 2018 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV:VHI) announced today the introduction of WellLinc , a proprietary electronic health record (“EHR") interoperability solution [...]
Keryx Biopharmaceuticals Announces Fourth Quarter and Full Year 2017 Financial Results
07/02/2018
Fourth quarter 2017 total revenues of $18.7 million, including net U.S. Auryxia ® (ferric citrate) product sales of $17.3 million Full year 2017 total revenues of $60.6 million; net U.S. Auryxia product sales more than [...]
Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss Third Quarter Financial Results on February 12, 2018
07/02/2018
NORTHVALE, N.J., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCQB:ELTP), a specialty pharmaceutical company developing a pipeline of abuse-deterrent opioids and niche [...]
Akcea Completes Enrollment in Phase 2b Study of AKCEA-APO(a)-LRx
07/02/2018
CAMBRIDGE, Mass., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ: AKCA ), today announced it had completed enrollment of a Phase 2b clinical study of investigational drug AKCEA-APO(a)-L Rx . Akcea is [...]
Humanigen Appoints Rainer Boehm, M.D., to Board of Directors
07/02/2018
BRISBANE, Calif., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Humanigen, Inc. (OTCQB:HGEN), a biopharmaceutical company pursuing cutting-edge science to develop its proprietary monoclonal antibodies for immunotherapy and oncology [...]
Coloplast acquires IncoCare Gunhild Vieler GmbH
07/02/2018
Coloplast A/S acquires the German direct-to-consumer homecare company IncoCare Gunhild Vieler GmbH (IncoCare) to further strengthen its position in Germany. Together, Coloplast and IncoCare will bring innovative [...]
Epizyme to Participate in Leerink Partners 7th Annual Global Healthcare Conference
07/02/2018
CAMBRIDGE, Mass., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Epizyme, Inc. (NASDAQ: EPZM ), a clinical-stage biopharmaceutical company creating novel epigenetic therapies, today announced that management will participate in a [...]
AnaptysBio To Present Data from ANB020 Phase 2a Atopic Dermatitis Trial at AAD Annual Meeting
07/02/2018
SAN DIEGO, Feb. 07, 2018 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB ), a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation [...]
Clementia to Participate in Leerink Partners 7th Annual Global Healthcare Conference
07/02/2018
MONTREAL, Quebec, Feb. 07, 2018 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (NASDAQ: CMTA ), a clinical-stage biopharmaceutical company innovating new treatments for people with ultra-rare bone disorders and [...]
Clementia Annonce qu’elle Participera à la 7e Conférence Annuelle Mondiale sur les Soins de Santé Leerink Partners (« Leerink Partners 7th Annual Global Healthcare Conference »)
07/02/2018
MONTRÉAL, Québec, 07 févr. 2018 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (NASDAQ: CMTA ), une société biopharmaceutique au stade clinique proposant des traitements novateurs pour les personnes atteintes de [...]

Pages